Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S. Starting in April, providers with a Quest account will be able to order ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.

Scientists have developed a new artificial intelligence–powered blood test that may be able to detect early signs of serious ...

Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...

Rohit Loomba, MD, senior author of the study, professor of medicine at UC San Diego School of Medicine and gastroenterologist and hepatologist at UC San Diego Health. Researchers at University of ...

Add Yahoo as a preferred source to see more of our stories on Google. If there are two things The Pitt has proven it excels at, it's tugging on our heartstrings and introducing us to horrifying new ...

Sergio Perez testing for Red Bull during the 2022 preseason F1 test in Barcelona. LLUIS GENE / Getty Images After a short offseason and the biggest set of car design rule changes in recent history, ...

Noninvasive liver diagnostic devices are transforming the detection and management of liver disease. The leading device-based solutions showcase this innovative technology and offer numerous clinical ...

I’d steer clear of AI Overviews everyday if I were you. Editorial Note: Talk Android may contain affiliate links on some articles. If you make a purchase through these links, we will earn a commission ...

The start-up Function will send practically anyone to a lab for extensive medical testing, no physical required. Is that a good thing? By Kristen V. Brown As Kimberly Crisp approached middle age, ...

Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and improve hepatic vascular function in cirrhosis. The ...

Using human liver samples and a mouse model of cirrhosis, researchers identified epigenetic overactivation of the inflammatory PAF–PAF-R pathway in hepatic macrophages as a key driver of liver damage.